General Information of the Compound
Compound ID
CP0577740
Compound Name
Benvitimod
    Show/Hide
Synonyms
GSK-2894512
GSK2894512
Tapinarof
    Show/Hide
Structure
Formula
C17H18O2
Molecular Weight
254.329
Canonical SMILES
CC(C)c1c(O)cc(\C=C\c2ccccc2)cc1O
    Show/Hide
InChI
InChI=1S/C17H18O2/c1-12(2)17-15(18)10-14(11-16(17)19)9-8-13-6-4-3-5-7-13/h3-12,18-19H,1-2H3/b9-8+
    Show/Hide
InChIKey
ZISJNXNHJRQYJO-CMDGGOBGSA-N
CAS
79338-84-4
Physicochemical Property
logP
4.3916
Rotatable Bonds
3
Heavy Atom Count
19
Polar Areas
40.46
Hydrogen Bond Donor Count
2
Hydrogen Bond Acceptor Count
2
Complexity
19

"RO5" indicates the cutoff set by lipinski's rule of five:

(1) Molecular weight less than 500 Dalton;

(2) xlogp less than 5;

(3) No more than 5 hbonddonor (Hydrogen Bond Donor Count);

(4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count);

(5) No more than 10 rotbonds (Rotatable Bond Count).

    Show/Hide
Click to Show/Hide the External Link(s) of This Compound
PubChem ID
CID: 6439522
SID: 14823557
ChEMBL ID
CHEMBL259571
DrugBank ID
DB06083
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound

Compound
Cell Line
Protein

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT02265, Aryl hydrocarbon receptor
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000704 HepG2-Lucia AhR Homo sapiens (Human)  1
1
EC50 = 27.34 nM
   TI
   LI
   LO
   TS
Clinical Information about the Compound
Drug 1 ( Tapinarof )
Drug Name Tapinarof
Company Dermavant
Indication
Plaque psoriasis
Approved
Psoriasis vulgaris
Phase 2
Atopic dermatitis
Phase 2
Plaque psoriasis
Phase 2
Target(s)
Aryl hydrocarbon receptor (AHR)
Agonist